Royal Bank of Canada »

United Therapeutics Corporation shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2011-09-30 $8.8M 273k 32.26
2011-06-30 $13M 197k 64.52

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Geode Capital Management
FMR
LSV Asset Management
AQR Capital Management
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Pacer Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation